All Episodes
Oncology for the Inquisitive Mind — 226 episodes
208. ASCO 2026 - The Plenary Episode - Part 3
207. ASCO 2026 - Agents of the Future - Part 2
206. ASCO 2026 - Part 1
205. ESTRO update with A/Prof Steven David
204. Jake Messier on Living with Metastatic Male Breast Cancer
203. Back to Basics - Early Pancreatic Cancer
202. Back to Basics - Advanced Pancreatic Cancer
201. Back to Basics - Advanced Gastric/GOJ Cancer
200. Back to Basics - Early Gastric Cancer
199. Back to Basics - Metastatic Colorectal Cancer - last line options
198. Back to Basics - Early Oesophageal Cancer
197. Back to Basics - Metastatic Colorectal Cancer - HER2 positive disease and PI3K mutations
196. Back to Basics - Metastatic Colorectal Cancer - BRAFV600E and KRAS
195. Back to Basics - Immunotherapy in Metastatic Colorectal Cancer
194. Back to Basics - Metastatic Colorectal Cancer
193. Genitourinary Cancers and Prof Jonathan E Rosenberg MD
192. Back to Basics - Early Colorectal Cancer - Part 2!
191. Back to Basics - Early Colorectal Cancer
190. Back to Basics - Mesothelioma
189. Back to Basics - Extensive Stage Small Cell Lung Cancer
188. Gastrointestinal Cancer and Professor Jenny Seligmann
187. ESMO Awards - Episode 7
186. ESMO Awards - Episode 6
185. ESMO Awards - Episode 5
184. ESMO Awards - Episode 4
183. ESMO Awards - Episode 3
182. ESMO Awards - Episode 2
182. ESMO Awards - Episode 1
181. Back to Basics - Limited Stage Small Cell Lung Cancer
180. Back to Basics - Metastatic NSCLC feat. KRAS and MET mutations
179. Back to Basics - Metastatic NSCLC feat. EGFR and ALK Driver Mutations
178. Back to Basics - Metastatic Non Small Cell Lung Cancer (mNSCLCa)
177. Back to Basics - Early Non Small Cell Lung Cancer
176. Back to Basics - Germ Cell Tumours (part 2)
175. Back to Basics - Germ Cell Tumours (part 1)
174. Back to Basics - Non Clear-Cell Renal Cell Cancer (RCC)
173. NECTA (New South Wales Early Phase Clinical Trials Alliance) - The Origin Story
172. Back to Basics - Advanced ccRCC
171. Back to Basics - Early Clear Cell Renal Cell Cancer (ccRCC)
170. Back to Basics - Adjuvant Urothelial Cancer
169. ASCO 2025 - Colorectal Cancer with Prof Jeanne Tie
168. ASCO 2025 - Early Breast Cancer with Dr. Belinda Yeo
167. ASCO 2025 - Upper GI and Hepatobiliary Cancer with Dr. James McCracken
166. ASCO 2025 - Gynecological Oncology with Dr. Prachi Bhave
165. ASCO 2025 - Palliative Care with Dr. Janet Abrahm
164. ASCO 2025 - Lung Cancer with Dr. Ned McNamee
163. ASCO 2025 - Genitourinary Cancers (Bladder and Renal) with Dr. Enrique Grande
162. ASCO 2025 - Genitourinary Cancers (Prostate) with Dr. Anthony Joshua
161. ASCO 2025 - Breast Cancer with Dr. Adam Brufsky
160. ASCO 2025 - Plenary Part 2
159. ASCO 2025 - Plenary Part 1
158. Back to Basics - Metastatic Urothelial (Bladder) Cancer
157. Back to Basics - Early Bladder Cancer
156. Back to Basics - Prostate Cancer - Biochemical Recurrence and Oligometastatic Disease Control
155. Back to Basics - Theranostics and Prostate Cancer
154. Back to Basics - Non Metastatic and Metastatic Prostate Cancer - The Journey Continues
153. Inflammatory Breast Cancer with Dr Massimo Cristofanilli, M.D.
152. Back to Basics - High Volume Metastatic Prostate Cancer
151. Back to Basics - Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer
150. Back to Basics - Recurrence-Score Assays in Early Breast Cancer
149. Back to Basics - Metastatic Hormone Sensitive Prostate Cancer
148. Back to Basics - Metastatic Triple Positive (HER2) Breast Cancer
147. Back to Basics - Metastatic Triple Negative Breast Cancer
146. Back to Basics - BRCA mutation and Breast Cancer Management
145. Back to Basics - Metastatic Hormone Receptor Positive Breast Cancer
144. Back to Basics - Early Triple Negative Breast Cancer
143. San Antonio Breast Cancer Symposium 2024 - Part 2
142. San Antonio Breast Cancer Symposium 2024 - Part 1
141. Back to Basics - The role of endocrine therapy in Breast Cancer
140. Back to Basics - Adjuvant HER2 Breast Cancer (Part 2)
139. Back to Basics - Early HER2 Breast Cancer
138. Back to Basics - Adjuvant CDK4/6 inhibitors in Early Breast Cancer
137. Back to Basics - High Risk Breast Cancer
136. Evolving landscape of Genitourinary Cancers (Bladder Cancer) - Prof Enrique Grande
135. ESMO 2024 - Breast Cancer with Dr Adam Brufsky
134. ESMO 2024 - Lung Cancer with Dr Ned McNamee
133. ESMO 2024 - Genitourinary Cancers with Prof Anthony Joshua
132. ESMO 2024 - Colorectal Cancer with Dr Geoffrey Chong
131. ESMO 2024 - Plenary Special
130. ESMO 2024 - Day 4
129. ESMO 2024 - Day 3
128. ESMO 2024 - Day 2
127. ESMO 2024 - Day 1
126. Ocular Melanoma and Prostate Cancer with A/Prof Anthony Joshua
125. Spotlight - Biotech ImmVirX with Dr Malcolm McColl and Prof Darren Shafren
124. Metastatic HER2- positive breast cancer
123. Spotlight: MARIPOSA for EGFRmut Lung Cancer
122. Palliative Care with Dr Janet Abrahm
121. Dr Elias Chandran, the NCI and Urothelial Caricinoma
120. Artificial Intelligence & Cancer with Professor Meredith Broussard
119. ASCO 2024 - Plenary Session
118. ASCO 2024 - Sarcoma
117. ASCO 2024 - Central Nervous System
116. ASCO 2024 - Early Lung Cancer & Mesothelioma
115. ASCO 2024 - Head and Neck Cancer
114. ASCO 2024 - Early Colorectal Cancer
113. ASCO 2024 - Metastatic Colorectal Cancer
112. ASCO 2024 - Upper Gastrointestinal and Hepatobiliary Cancers
111. ASCO 2024 - Genitourinary Cancers (Prostate/Penile)
110. ASCO 2024 - Genitourinary Cancers (Bladder/Kidney)
109. ASCO 2024 - Early Breast Cancer
108. ASCO 2024 - Metastatic Breast Cancer
107. ASCO 2024 - Gynaecological Cancer
106. ASCO 2024 - Melanoma
105. ASCO 2024 - Metastatic Non Small Cell Lung Cancer
104. Metastatic Gastric and GOJ Cancer
103. Metastatic Colorectal Cancer
102. Hepatocellular Carcinoma
Oncosnacks 14: Bevacizumab Toxicity (Part 1)
101. Castration-Resistant Prostate Cancer Update
100. 100th Episode Bonanza
99. Early Mutation-Driver Positive NSCLC
98. Breast Cancer with Dr Adam Brufsky
Fireside Chats 3: Colorectal Cancer in Young People
Oncosnacks 13: Pancreatic Cancer - NAPOLI-3 Trial Update
97. Spotlight: Advanced Breast Cancer - Which CDK4/6 Inhibitor is Best?
96. Second Line Treatment of Melanoma
95. ASCO GU 2024 Spectacular (Part 2)
94. ASCO GU 2024 Spectacular (Part 1)
93. On the Road with Prof. Elgene Lim
92. On the Road with Dr. Robert Mayer
91. On the Road with Dr. Ann Partridge
90. On the Road with Dr. Harold J Burstein
89. Spotlight - Biotech: Interview with Dr Jeff Jones from Cullinan Oncology
88. On the Road with Dr. Geoffrey Shapiro
87. On the Road with Dr. Eric Winer
86. On the Road with Dr. Erica Mayer
85. Spotlight: Year in Retrospect: 2023
84. World Conference on Lung Cancer (part 2)
83. World Conference on Lung Cancer (part 1)
Oncosnacks 12: Enfortumab Vedotin skin toxicity management
82. Metastatic triple negative breast cancer (TNBC)
Fireside Chats 2. Time Toxicity in Early Phase Trials
81. San Antonio Breast Cancer Symposium Update
80. ESMO 2023 - Plenary Session
79. ESMO 2023 - Gynaecological Oncology
78. ESMO 2023 - Skin Cancer and Melanoma
77. ESMO 2023 - Non Small Cell Lung Cancer
76. ESMO 2023 - Colorectal Cancer (Part 2)
75. ESMO 2023 - Colorectal Cancer (Part 1)
74. ESMO 2023 - Upper GI and Hepatobiliary Cancer
73. ESMO 2023 - Genitourinary Cancers - Prostate and Bladder
72. ESMO 2023 - Early Breast Cancer (Part 2)
71. ESMO 2023 - Early Breast Cancer (Part 1)
70. ESMO 2023 - Small Cell Lung Cancer
69. ESMO 2023 - Metastatic Breast Cancer
68. ESMO 2023 - Central Nervous System Tumors
67. Spotlight: Head and Neck Cancer: Docetaxel as a Radiosensitiser
OncoSnacks 11: Pulmonary Embolism & Deep Vein Thrombosis in the context of malignancy
66. Gynae-Oncology with Dr Vish Boolell
65. Meredith Cummins - CEO of Neuroendocrine Cancer Australia
64. Metastatic Neuroendocrine Carcinomas
63. Advanced Grade 3 Neuroendocrine Tumours - Chemotherapy options
62. Advanced Neuroendocrine Tumour - Later Lines of Therapy
61. Fireside Chats: What We Call "Cancer"
60. Advanced Neuroendocrine Tumours - Part 1
59. Testicular Cancer - Part 2
OncoSnacks 10: Thrombophlebitis and Superficial Venous Thrombosis
58. Testicular Cancer - Part 1
57. ROS1 and KRAS Mutated Lung Cancer
56. ALK-mutant Metastatic Lung Cancer
55. Extensive-Stage Small Cell Lung Cancer
OncoSnacks 9: Chemotherapy Extravasation
54. Cancer Survivorship with Dr Ash Malalasekera
53. Ductal carcinoma in situ (DCIS) and Lobular carcinoma in situ (LCIS)
52. ASCO 2023 - Plenary Session
51. ASCO 2023 - Melanoma & Head and Neck
50. ASCO 2023 - Metastatic NSCLC
49. ASCO 2023 - Metastatic Breast Cancer
48. ASCO 2023 - Prostate, Bladder and Renal Cancer
47. ASCO 2023 - Colorectal Cancer
46. ASCO 2023 - Early Lung Cancer
45. ASCO 2023 - Gynaecologic Cancers
44. ASCO 2023 - Central Nervous System
43. ASCO 2023 - Early Hormone Receptor Positive Breast Cancer
42. ASCO 2023 - Gastroesophageal, Pancreatic and Hepatobiliary update
41. Pre-ASCO Appetizer
OncoSnacks 8: Chemotherapy-induced Peripheral Neuropathy
40. Advanced Endometrial Cancer
39. Leadership, Policy and Teletrials with Prof Sabe Sabesan
OncoSnacks 7: Cardiotoxicity with Dr Mark Nolan
38. Adenoid Cystic Carcinoma - Rare Cancer Snapshot
37. Metastatic Castrate Resistant Prostate Cancer- Theranostics and Chemotherapy
36. Early Drug Development and Mentorship with Dr Jenny Liu
35. Castration-Resistant Prostate Cancer
OncoSnacks 6: Immunotherapy-related Thyroid Disorders with Endocrinologist Dr Dahlia Davidoff
34. Hormone-Sensitive Prostate Cancer (2)
33. Ageism and Geriatric Oncology with Dr Michael Krasovitsky
Oncosnacks 5: Anti-Cancer Treatment-Induced Alopecia
32. Oligometastatic Colorectal Cancer - Is it curable?
31. Metastatic Head and Neck Cancer
30. Early Head and Neck Cancer
OncoSnacks 4: Immune-Mediated Pneumonitis
29. Metastatic Hormone Receptor (HR) Positive Breast Cancer
28. ASCO GU 2023 Spectacular
OncoSnacks 3: Chemotherapy-Induced Nausea and Vomiting
27. High Grade Gliomas and Glioblastoma Multiforme (GBM)
26. Neuro-Oncology
OncoSnacks 2: Chemotherapy-induced Diarrhea
25. ASCO GI 2023 Extravaganza
24. Metastatic Renal Cell Cancer
OncoSnacks 1: Mucositis
23. Early Renal Cell Cancer
22. Non Melanoma Skin Cancers - BCC and Merkle Cell Carcinoma
21. Beginning a Career with Andrew Jensen
20. Early-Stage Triple Negative Breast Cancer (TNBC)
19. Early non-Small Cell Lung Cancer (NSCLC)
18. Metastatic Colorectal Cancer
17. Prostate Cancer with Dr Megan Crumbaker
16. Metastatic Oesophageal/GOJ/Gastric Cancer
15. Early Gastric and Oesophageal Cancer
14. Advanced Ovarian Cancer
13. Breast Cancer with Dr Belinda Yeo
12. Metastatic Pancreatic Cancer
11. Metastatic HER2- Positive Breast Cancer
10. Early HER2-Positive Breast Cancer
9. Metastatic Urothelial Cancer
8. ESMO 2022 Highlights
7. ESMO 2022 Highlights
6. Hepatobiliary Cancer
5. Early Hormone Receptor-Positive Breast Cancer
4. Metastatic Non-Small Cell Lung Cancer
3. Mesothelioma
2. Metastatic Melanoma
1. Hormone Sensitive Prostate Cancer
Introducing: Oncology for the Inquisitive Mind